Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Peptides in Vials/ BPC-157
In stock
BPC-157

BPC-157

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

How to reconstitute BPC-157 — stock calculator
Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a protective protein in human gastric juice, and one of the most studied compounds in regenerative and cytoprotective research. Sequence GEPPPGKPADDAGLV; CAS 137525-51-0; molecular weight 1419.53 g/mol; supplied lyophilised at ≥99% purity by HPLC. For laboratory research use only; not for human or veterinary use.

First identified in a protein that protects the lining of the stomach, BPC-157 (Body Protection Compound-157, also designated PL 14736) is a synthetic pentadecapeptide — a 15-amino-acid chain (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) prized for its stability. Unusually robust in aqueous solution and resistant to gastric acid, it has become one of the most extensively investigated molecules in regenerative and cytoprotective research.

A peptide born from the body's own defences. BPC-157 is derived from a naturally occurring protective sequence found in human gastric juice — the tissue that withstands one of the harshest environments in the body. Researchers isolated and stabilised this fragment to study how the organism shields and repairs itself, and since the late 1990s the Zagreb group led by Sikirić and colleagues has built much of the foundational literature around it (Sikirić et al., 2024).

What the research explores. Rather than acting on a single target, BPC-157 is studied as a pleiotropic agent — one that appears to influence several repair pathways at once, with the nitric-oxide (NO) system and angiogenic, growth-factor signalling recurring throughout the literature. Investigations cluster into four broad domains:

  • Connective-tissue & musculoskeletal repair — tendon, ligament, muscle and bone models; a widely cited in-vitro study reported increased tendon-fibroblast outgrowth, survival and migration (Chang et al., 2011).
  • Gastrointestinal research — the peptide's original setting, from gastric-mucosal protection to intestinal-anastomosis and fistula-healing models.
  • Angiogenesis & the nitric-oxide system — vascular and endothelial work probing NO- and eNOS-mediated pathways (Hsieh et al., 2020).
  • Neurological models — experimental traumatic and ischaemic central-nervous-system injury.

All of the above derives from in-vitro and animal studies and is provided strictly for scientific context; it does not constitute evidence of safety or efficacy in humans. Every research statement maps to a verifiable, peer-reviewed source — with PMID and DOI — under the Scientific References tab.

Physicochemical profile. CAS 137525-51-0 · Molecular formula C₆₂H₉₈N₁₆O₂₂ · Molecular weight 1419.53 g/mol · Sequence GEPPPGKPADDAGLV · Soluble in water (≈1 mg/mL) and standard aqueous buffers.

Specification & quality. Each individually sealed vial contains 10 mg of BPC-157 supplied as a sterile, lyophilised white powder at ≥99% purity by reversed-phase HPLC. Every batch is independently third-party tested, with identity and purity confirmed by HPLC and mass spectrometry; a Certificate of Analysis is available for verified research accounts. Store lyophilised at −20 °C, protected from light and moisture.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number137525-51-0
Molecular formulaC₆₂H₉₈N₁₆O₂₂
Molecular weight1419.53
SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity10mg/vial
SolubilitySoluble in water at 1mg/mL
StorageStore at -20°C, protect from light
ReconstitutionReconstitute with bacteriostatic water or sterile saline. Allow to stand at room temperature before use.
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Mateescu DM, Gavrilescu DM, Constantinescu FE, Oancea C, Ilie AC, Folescu R, et al. BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers. Pharmaceutics. 2026;18(5). PMID: 42198317. doi:10.3390/pharmaceutics18050625. PubMed 02 Yuan C, Demers A, Silva-Ortiz V, Hasoon JJ, Lee W, Dave K, et al. From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. Int J Mol Sci. 2026;27(6). PMID: 41898733. doi:10.3390/ijms27062876. PubMed 03 McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025;18(12):611-619. PMID: 40789979. doi:10.1007/s12178-025-09990-7. PubMed 04 Sikiric P, Boban Blagaic A, Strbe S, Beketic Oreskovic L, Oreskovic I, Sikiric S, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals (Basel). 2024;17(4). PMID: 38675421. doi:10.3390/ph17040461. PubMed 05 Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80. PMID: 21030672. doi:10.1152/japplphysiol.00945.2010. PubMed 06 Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-61. PMID: 20225319. doi:10.1002/jor.21107. PubMed 07 Sebecić B, Nikolić V, Sikirić P, Seiwerth S, Sosa T, Patrlj L, et al. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone. 1999;24(3):195-202. PMID: 10071911. doi:10.1016/s8756-3282(98)00180-x. PubMed 08 Petek M, Sikiric P, Anic T, Buljat G, Separovic J, Stancic-Rokotov D, et al. Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice. J Physiol Paris. 1999;93(6):501-4. PMID: 10672996. doi:10.1016/s0928-4257(99)00120-5. PubMed 09 Vukusic D, Zenko Sever A, Sever M, Drmic D, Milavic M, Sikiric S, et al. Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint. J Physiol Pharmacol. 2024;75(1). PMID: 38583442. doi:10.26402/jpp.2024.1.09. PubMed 10 Yildirim AK, Dastan AO, Demeli Ertus M, Ensarioglu M, Karabacak K, Pehlivanoglu B. Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery. J Clin Med. 2026;15(9). PMID: 42123221. doi:10.3390/jcm15093488. PubMed 11 Hsieh MJ, Lee CH, Chueh HY, Chang GJ, Huang HY, Lin Y, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep. 2020;10(1):17078. PMID: 33051481. doi:10.1038/s41598-020-74022-y. PubMed 12 Tudor M, Jandric I, Marovic A, Gjurasin M, Perovic D, Radic B, et al. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul Pept. 2010;160(1-3):26-32. PMID: 19931318. doi:10.1016/j.regpep.2009.11.012. PubMed 13 Perovic D, Milavic M, Dokuzovic S, Krezic I, Gojkovic S, Vranes H, et al. Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy. Curr Issues Mol Biol. 2022;44(5):1901-1927. PMID: 35678659. doi:10.3390/cimb44050130. PubMed 14 Masnec S, Kokot A, Zlatar M, Kalauz M, Kunjko K, Radic B, et al. Perforating corneal injury in rat and pentadecapeptide BPC 157. Exp Eye Res. 2015;136:9-15. PMID: 25912999. doi:10.1016/j.exer.2015.04.016. PubMed 15 He L, Feng D, Guo H, Zhou Y, Li Z, Zhang K, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. 2022;13:1026182. PMID: 36588717. doi:10.3389/fphar.2022.1026182. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

BPC-157 (Body Protection Compound-157, also designated PL 14736) is a synthetic 15-amino-acid peptide whose sequence was derived from a protein found in gastric juice. It is supplied strictly as a research-use-only reference compound for in vitro and animal cytoprotection and tissue-repair studies, not for human or veterinary use.

BPC-157 is a 15-amino-acid synthetic peptide derived from a gastric protein, studied for cytoprotection and angiogenesis in vitro. TB-500 is a much larger 43-residue peptide corresponding to thymosin beta-4, studied for actin binding and cell migration. They act through different mechanisms, which is why both are used as distinct regenerative-research reagents.

They are studied as complementary, not redundant, reagents. BPC-157 (a 15-mer gastric-derived peptide) and TB-500 (a 43-residue thymosin beta-4 peptide) act through different molecular pathways in tissue-repair models, which is the rationale for the co-formulated BPC-157 + TB-500 blend. For research use only, in vitro and animal models.

Standalone BPC-157 is a single 10 mg peptide for isolating its effects in research. GLOW co-formulates it with GHK-Cu (50 mg) and TB-500 (10 mg); KLOW adds KPV (10 mg) as a fourth component. Choose the standalone to study one variable, or a blend to investigate the peptides together. Research use only.

Yes. Condor Research supplies BPC-157 strictly as a Research Use Only (in vitro) reference compound to professionals and institutions, not as a medicine, supplement or product for human or veterinary use. Buyers are responsible for confirming import legality in their own country. Questions: info@condorresearch.com.

Yes. Every BPC-157 batch is tested by an independent third-party laboratory by HPLC for identity and purity (>=99%), with mass spectrometry confirmation, and ships with a batch-specific Certificate of Analysis. To request the COA for a specific lot before ordering, contact info@condorresearch.com.

This BPC-157 has the molecular formula C62H98N16O22 and a molecular weight of 1419.53 (CAS 137525-51-0). Its pentadecapeptide sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Identity and mass are confirmed by HPLC and mass spectrometry on each batch, and the values are documented in the lot-specific Certificate of Analysis supplied with the product.

Store the sealed BPC-157 vial at -20C, protected from light; shelf life is 24 months from manufacture. For laboratory preparation it is reconstituted in water (listed solubility 1 mg/mL). All handling is for in vitro and animal research only; no preparation here is intended for human or veterinary use.

The 1 mg/mL figure is the verified solubility reference used for laboratory preparation, not necessarily an absolute ceiling. For a 10 mg vial, adding 10 mL of diluent yields a 1 mg/mL solution. For concentrations above this, contact info@condorresearch.com. This data is for in vitro research preparation only.

Yes. Orders ship from the EU warehouse in plain, neutral outer packaging with tracking, and each vial carries the required Research Use Only laboratory labeling. Customs declarations are made truthfully as RUO research material with correct classification and value; contents are never mislabeled or undervalued. Questions: info@condorresearch.com.

Lyophilized BPC-157 is stable for short room-temperature transit, so cold packs are generally not required for shipping; brief delivery times within Europe do not compromise the powder. On arrival, store the sealed vial at -20C, protected from light, for long-term stability. Questions: info@condorresearch.com.

If a vial arrives damaged or non-conforming, notify info@condorresearch.com ideally within 48 hours with photos, and a replacement, reshipment or store credit can be arranged. Each batch is independently HPLC-tested at >=99% with a Certificate of Analysis backing the stated purity. Sealed laboratory goods are otherwise final sale (B2B).

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.7
37 verified reviews
5
78%
4
16%
3
3%
2
3%
1
0%
Apr 2026
Reliable, well documented

Solubility and stability were as described. Knocked one star only because express shipping options are limited, but quality is not in question.

P. Andersson · Research institute · SE Verified purchase
Mar 2026
Reproducible across batches

Third order with Condor. Batch-to-batch variation is minimal, which matters for our longitudinal work. The mono-labelled vials are easy to track.

Dr. R. Costa · Academic lab · PT Verified purchase
Mar 2026
Exactly what research needs

No marketing fluff — just characterised material with paperwork. The data sheet and CAS matched our records precisely.

J. Meijer · Biotech R&D · NL Verified purchase
Feb 2026
High purity, clear labelling

Lyophilised cake was uniform and dissolved fully. Would appreciate a digital COA portal, but the PDF on request worked fine.

Dr. A. Bianchi · University · IT Verified purchase
Jan 2026
Trustworthy supplier

Identity by MS confirmed in our facility. Communication around storage and handling was precise and professional.

K. Wójcik · Research group · PL Verified purchase

Related compounds